Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epirubicin for the Treatment of Sepsis and Septic Shock (EPOS-1): study protocol for a randomised, placebo-controlled phase IIa dose-escalation trial.
Thomas-Rüddel D, Bauer M, Moita LF, Helbig C, Schlattmann P, Ehler J, Rahmel T, Meybohm P, Gründling M, Schenk H, Köcher T, Brunkhorst FM, Gräler M, Heger AJ, Weis S; EPOS-1 study group; SepNetCriticalCare TrialsGroup. Thomas-Rüddel D, et al. BMJ Open. 2024 Apr 22;14(4):e075158. doi: 10.1136/bmjopen-2023-075158. BMJ Open. 2024. PMID: 38653508 Free PMC article.
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Fleischmann M, Schnetzke U, Frietsch JJ, Sayer HG, Schrenk K, Hammersen J, Glaser A, Hilgendorf I, Hochhaus A, Scholl S. Fleischmann M, et al. Among authors: hammersen j. J Cancer Res Clin Oncol. 2022 Jun;148(6):1481-1492. doi: 10.1007/s00432-021-03733-0. Epub 2021 Jul 23. J Cancer Res Clin Oncol. 2022. PMID: 34297206 Free PMC article.
The impact of specific cytokine directed treatment on severe COVID-19.
Reuken PA, Rüthrich MM, Hochhaus A, Hammersen J, Bauer M, La Rosée P, La Rosée F, Stallmach A. Reuken PA, et al. Among authors: hammersen j. Leukemia. 2021 Dec;35(12):3613-3615. doi: 10.1038/s41375-021-01411-1. Epub 2021 Sep 7. Leukemia. 2021. PMID: 34493799 Free PMC article. No abstract available.
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy.
Mühleck R, Scholl S, Hilgendorf I, Schrenk K, Hammersen J, Frietsch JJ, Fleischmann M, Sayer HG, Glaser A, Hochhaus A, Schnetzke U. Mühleck R, et al. Among authors: hammersen j. J Cancer Res Clin Oncol. 2022 Sep;148(9):2539-2548. doi: 10.1007/s00432-021-03821-1. Epub 2021 Oct 5. J Cancer Res Clin Oncol. 2022. PMID: 34609595 Free PMC article.
The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.
Hammersen J, Birndt S, Döhner K, Reuken P, Stallmach A, Sauerbrey P, La Rosée F, Pfirrmann M, Fabisch C, Weiss M, Träger K, Bremer H, Russo S, Illerhaus G, Drömann D, Schneider S, La Rosée P, Hochhaus A. Hammersen J, et al. Leukemia. 2023 Sep;37(9):1879-1886. doi: 10.1038/s41375-023-01979-w. Epub 2023 Jul 28. Leukemia. 2023. PMID: 37507425 Free PMC article.
Detection of a rare JAK2exon13InDel-mutation in chronic eosinophilic leukemia with bilateral cerebral infarctions and Löffler endocarditis.
Eisenach S, Zinke J, Brämer D, Hartinger S, Haferlach T, Kreipe HH, Hammersen J, Hamadanchi A, Otto S, Schulze PC, Bürckenmeyer F, Teichgräber U, Hochhaus A, Witte OW, Günther A, Schrenk KG. Eisenach S, et al. Among authors: hammersen j. Ann Hematol. 2024 Jan;103(1):363-365. doi: 10.1007/s00277-023-05490-1. Epub 2023 Oct 16. Ann Hematol. 2024. PMID: 37843619 Free PMC article. No abstract available.
50 results